Audran, Clochon, Ethgen, Mazieres, Renier (1989) Treatment of Paget's disease of bone with (4-chloro-phenyl) thiomethylene bisphosphonate. Clin. Rheum. 8:71-79.
Barbier, Emonts-Alt, Breliere, Ethgen (1990) In vitro and in vivo osseous pharmacological profile of tiludronate. Implications for osteoporosis treatment. Osteoporosis 1990 , C. Christiansen, K. Overgaard, Osteopress ApS Publ, Copenhagen; 1127-1130.
Boonekamp, Van der Wee-Pals, Van Wijk-Van Lenncp, Thesing, Bijvoet (1986) Two modes of action of bisphosphonates on osteoclastic resorption of mineralized matrix. Bone Mineral 1:27-39.
Charhon, Meunier, Ethgen, Lacheretz, Breliere, Roncucci (1985) Histomorphometric analysis of bone biopsies of baboons treated with SR41319B, a new diphosphonate. Calcif. Tissue Int. 38:S33.
de Vernejoul, Jiang, Lacheretz, Barbier, Geusens, Morieux, Pfersdorff (1990) Prevention of bone loss following tiludronate administration to ovariectomized beagle dogs. Osteoporosis 1990 , C. Christiansen, K. Overgaard, Osteopress ApS Publ, Copenhagen; 1119-1122.
Emonts-Alt, Brelière, Roncucci (1985) Effects of 1-hydroxyethylidene-1, 1 bisphosphonate and (chloro-4 phenyl) thiomethylene bisphosphonic acid (SR41319B) on the mononuclear cell factor mediated release of neutral proteinases by articular chondrocytes and synovial cells. Biochem. Pharmacol. 34:4043-4049.
Geusens, Nijs, Van Des Perre, Vanaudekercke, Lowet, Barbier, Lacheretz, Remandet, Goovaerts, Dequeker (1990) Longitudinal skeletal effect of tiludronate on bone density and strength in monkeys. Osteoporosis 1990 , C. Christiansen, K. Overgaard, Osteopress ApS Publ, Copenhagen; 366-367.
Harinck, Bijvoet, Blaksman, Dahlinghaus-Nienhuys (1987) Efficacious management with aminobisphosphonate (APD) in Paget's disease of bone. Clin. Orthop. Rel. Res. 217:79-98.
Kanis, Gray (1987) Long-term follow-up observations on treatment of Paget's disease of bone. Clin. Orthop. Rel. Res. 217:99-125.
Lecart, Reginster, Deroisy, Denis, Sarlet, Franchimont (1989) Calcium and regulation of cell function. Calcified Tissue International 44(1 S):N29.
Lecart, Reginster, Deroisy, Ethgen, Sarlet, Franchimont (1990) Treatment of Paget's disease of bone with a five-day course of oral tiludronate. Osteoporosis 1990 , C. Christiansen, K. Overgaard, Osteopres Publ, Copenhagen; 400-401.
Nagant De Deuxchaisnes, Devogelaer, Malghem, Maldague, Cornet (1987) Quantitative computed tomography: Update 1987. Calcified Tissue International 41(2 S):P179.
Reginster, Jeugmans-Huynen, Albert, Denis, Deroisy, Lecart, Fontaine, Collette, Franchimont (1988) Biological and clinical assessment of a new bisphosphonate, (chloro-4 phenyl) thiomethylene bisphosphonate, in the treatment of Paget's disease of bone. Bone 9:349-354.
Reginster, Deroisy, Denis, Collette, Lecart, Sarlet, Ethgen, Franchimont (1989) Prevention of postmenopausal bone loss by tiludronate. Lancet 2:1469-1471.
Reginster, Deroisy, Lecart, Sarlet, Latour, Albert, Franchimont (1990) Role of antiosteoclastic drugs in prevention of postmenopausal Osteoporosis. Osteoporosis 1990 , C. Christiansen, K. Overgaard, Osteopress ApS Publ, Copenhagen; 971-975.
.
Roux, Listrat, Villette, Lessana-Leibowitch, Ethgen, Dougados, Amor (1991) Long-lasting dermatological lesions after tiludronate therapy. J. Bone Min. Res. 6(1 S):279.
Trechsel, Stutzer, Fleisch (1986) Hypercalcemia induced with an arotinoid in thyroparathyroidectomized rats. New model to study bone resorption. J. Clin. Invest. 80:1679-1686.
